News
-
-
PRESS RELEASE
Secarna Pharmaceuticals and Protalix Biotherapeutics Enter into Collaboration and Option Agreement
Secarna Pharmaceuticals and Protalix Biotherapeutics enter into collaboration and option agreement to develop oligonucleotide therapies for rare renal indications. Combine expertise in rare diseases and biologics -
-
-
-
-
-
PRESS RELEASE
Zentek Subsidiary Albany Graphite Corp. Achieves Near-Theoretical Anode Performance in Battery Suitability Independent Testing
Zentek Ltd.'s subsidiary Albany Graphite Corp achieves near theoretical anode performance in lithium-ion battery testing using ultrahigh purity Albany graphite, supporting North American battery supply chain -
-